Watershed Therapeutics
PrivateLast Round
Seed Round
Apr 14, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Watershed Therapeutics is a drug delivery company that develops a targeted technology for delivering long-term therapies directly to the bladder for conditions like bladder cancer and recurrent urinary tract infections.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Watershed Therapeutics Comparables
Compare Watershed Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 82% | |
| Vensica Medical | 76% | |
| UroGen Pharma Ltd. | 73% |
Watershed Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 14, 2026 | ||||
| Seed | Apr 19, 2023 | ||||
| Accelerator | Sep 6, 2022 | ||||
| Seed | Aug 1, 2022 |
Key People
Founding team and executive leadership
Watershed Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Seed |
| Sierra Angels | Seed |
| WTIA Startup Program | Seed, Accelerator |
| Washington Research Foundation Capital | Seed |
| Charleston Angel Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 134% MoM.
- Jun 20, 2026
Monthly visitors grew 290% MoM.
Watershed Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Watershed Therapeutics's valuation, stock price, and market status.
Is Watershed Therapeutics a public or private company?
Watershed Therapeutics is a private company.
What is the current stock price of Watershed Therapeutics?
Watershed Therapeutics is a private company, so its shares have no public market price. Caplight tracks Watershed Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Watershed Therapeutics worth (valuation)?
Valuation information for Watershed Therapeutics is not publicly available.
Can I buy Watershed Therapeutics stock?
Watershed Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Watershed Therapeutics's last funding round?
Watershed Therapeutics's most recent funding round was Seed Round on April 14, 2026.
Who are the main investors in Watershed Therapeutics?
Key investors in Watershed Therapeutics include WTIA Startup Program.
Will Watershed Therapeutics IPO soon?
No public IPO plans have been announced for Watershed Therapeutics.
How can I track Watershed Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Watershed Therapeutics's shares on secondary markets.